UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043784
Receipt number R000049931
Scientific Title A study of preoperative blood augmentation for transfusion-free surgery
Date of disclosure of the study information 2021/08/31
Last modified on 2023/07/05 15:45:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Preoperative blood augmentation for transfusion-free surgery

Acronym

PBA-TFS

Scientific Title

A study of preoperative blood augmentation for transfusion-free surgery

Scientific Title:Acronym

PBA-TFS

Region

Japan


Condition

Condition

Abdominal tumor

Classification by specialty

Gastrointestinal surgery Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The primary objective of this study is to examine the efficacy of preoperative blood augmentation for transfusion-free surgery

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Inversing Hb value to undergo transfusion-free surgery

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

1)patients whose religious belief causes them to decline blood transfusion
2)abdominal tumors which were needed to resection

Key exclusion criteria

patients who accept transfusion

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Norimitsu
Middle name
Last name Kurogi

Organization

Shonan Atsugi Hospital

Division name

surgery

Zip code

2438551

Address

118-1 Nurumizu Atsugi-city Kanagawa

TEL

046-223-3636

Email

norimitsuk@shonan-atsugi.jp


Public contact

Name of contact person

1st name Shunji
Middle name
Last name Kawamoto

Organization

Shonan Atsugi Hospital

Division name

surgery

Zip code

2438551

Address

118-1 Nurumizu Atsugi-city Kanagawa

TEL

046-223-3636

Homepage URL


Email

sijk0929@gmail.com


Sponsor or person

Institute

Shonan Atsugi Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Tokushukai Group Ethics Committee

Address

Emina Building 3F, 1-8-7, Koji-machi, Chiyoda-ku, Tokyo, Japan

Tel

03-3263-4801

Email

mirai-ec1@mirai-iryo.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 08 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

126

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2021 Year 03 Month 30 Day

Date of IRB

2021 Year 04 Month 30 Day

Anticipated trial start date

2021 Year 05 Month 01 Day

Last follow-up date

2021 Year 08 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2021 Year 03 Month 30 Day

Last modified on

2023 Year 07 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049931